| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Financial Officer | Chief Financial Officer
2 companies
Dulac Edward J III is a Chief Financial Officer at FATE THERAPEUTICS INC with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $1.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Financial Officer | Sell | 6,379 | $9.21 | $58,750.59 | -6.0% | +41.9% | - | |
| Jul 23, 2025 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Financial Officer | Sell | 7,462 | $14.02 | $104,617.24 | -6.6% | +89.4% | - | |
| Mar 4, 2024 | FATE Fate Therapeutics Inc | Chief Financial Officer | Sell | 2,447 | $7.77 | $19,013.19 | -2.4% | -48.2% | -86.6% | |
| Jan 29, 2024 | FATE Fate Therapeutics Inc | Chief Financial Officer | Sell | 1,849 | $5.00 | $9,245.00 | -1.7% | -29.4% | -77.3% | |
| Jan 9, 2024 | FATE Fate Therapeutics Inc | Chief Financial Officer | Sell | 7,028 | $4.37 | $30,712.36 | -6.2% | +52.2% | -62.1% | |
| Jan 2, 2024 | FATE Fate Therapeutics Inc | Chief Financial Officer | Sell | 5,182 | $3.66 | $18,966.12 | -4.4% | +91.9% | -51.5% | |
| Dec 18, 2023 | FATE Fate Therapeutics Inc | Chief Financial Officer | Sell | 1,585 | $3.50 | $5,547.50 | -1.3% | +123.5% | -40.3% | |
| Aug 18, 2023 | FATE Fate Therapeutics Inc | Chief Financial Officer | Sell | 4,718 | $2.80 | $13,210.40 | -3.8% | -14.4% | +22.3% | |
| Jul 5, 2023 | FATE Fate Therapeutics Inc | Chief Financial Officer | Sell | 5,182 | $4.83 | $25,029.06 | -4.0% | -62.1% | -34.8% | |
| Jan 10, 2023 | FATE Fate Therapeutics Inc | Chief Financial Officer | Sell | 7,331 | $5.24 | $38,414.44 | -5.4% | -0.2% | -16.8% |